Related references
Note: Only part of the references are listed.European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone
A. Potron et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Effect of applying the new CLSI imipenem susceptibility breakpoints for Enterobacteriaceae in Hong Kong
Pak-Leung Ho et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Comparison of Polymyxin B, Tigecycline, Cefepime, and Meropenem MICs for KPC-Producing Klebsiella pneumoniae by Broth Microdilution, Vitek 2, and Etest
Asma Lat et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance
Neil Woodford et al.
FEMS MICROBIOLOGY REVIEWS (2011)
Evaluation of a DNA Microarray, the Check-Points ESBL/KPC Array, for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and KPC Carbapenemases
T. Naas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
Mical Paul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae
Brandon Kitchel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Diversity of Escherichia coli Strains Producing Extended-Spectrum β-Lactamases in Spain: Second Nationwide Study
Miguel A. Diaz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
Brandon Kitchel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem
Scott A. Weisenberg et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli
Paul J. Rooney et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Prevalence and clonality of extended-spectrum beta-lactamases in Asia
P. M. Hawkey
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Extended-spectrum beta-lactamases in North America, 1987-2006
K. Bush
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Evaluation of the chromogenic Cica-β-Test for detecting extended-spectrum, AmpC and metallo-β-lactamases
D. M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia:: a systematic review and meta-analysis
Mitchell J. Schwaber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobactetiaceae
K. F. Anderson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
CTX-M: changing the face of ESBLs in Europe
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli
Cao Bin et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
bla(IMP-9) and its association with large plasmids carried by Pseudomonas aeruginosa isolates from the People's Republic of China
JH Xiong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Dissemination of the metallo-β-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia
AY Peleg et al.
CLINICAL INFECTIOUS DISEASES (2005)
Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations
D Andes et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates
P Giakkoupi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology
AM Queenan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula
D Maglio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK
N Woodford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes
PL Ho et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases:: Implications for the clinical microbiology laboratory
DL Paterson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 β-lactamase and lacking an outer membrane protein
TH Koh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
